GGenetics Read More Modifiable risk factors could double global kidney cancer cases by 2050September 27, 2025 Modifiable risk factors such as obesity, smoking, lack of exercise, diabetes and hypertension are projected to be one…
GGenetics Read More Myriad Genetics Announces Precise MRD Clinical DataSeptember 4, 2025 SALT LAKE CITY, Sept. 04, 2025 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular…